Atlas Trials

Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease

Clinical trial NCT02960503 · WITHDRAWN

Trial details

NCT number
NCT02960503
Sponsor
Vanderbilt University
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2016-09-01
Primary completion
2018-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.